96 related articles for article (PubMed ID: 2735238)
1. [A clinical study of prostatic carcinoma].
Hashimoto H; Sasaki M; Osanai H; Inagaki N; Yamauchi K; Nishihara M; Tokunaka S; Yachiku S
Hinyokika Kiyo; 1989 Feb; 35(2):271-5. PubMed ID: 2735238
[TBL] [Abstract][Full Text] [Related]
2. [Five-year trend in new patients with prostatic carcinoma].
Moriyama N; Akaza H; Sugimoto M; Taniguci J; Hara M; Fukutani K; Kitamura T; Higashihara E; Kishi H; Umeda T
Hinyokika Kiyo; 1988 Jun; 34(6):997-1001. PubMed ID: 3066215
[TBL] [Abstract][Full Text] [Related]
3. [A multimodal treatment of prostatic carcinoma and the 5-year survival rate].
Maruoka M; Miyauchi T; Nagayama T
Hinyokika Kiyo; 1989 Jan; 35(1):57-63. PubMed ID: 2729020
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of prostatic cancer--statistical analysis of 184 cases in the latest 21 years].
Yamashita A; Hayashi N; Sugimura Y; Yanagawa M; Arima K; Nakano S; Kimbara H; Tochigi H; Kawamura J
Hinyokika Kiyo; 1995 Jun; 41(6):447-53. PubMed ID: 7645452
[TBL] [Abstract][Full Text] [Related]
5. [Studies of progressive factors of stage A prostatic cancer].
Suzuki T; Shimizu T; Imai K; Yamanaka H; Suzuki K; Takahashi H
Hinyokika Kiyo; 1989 Feb; 35(2):259-63. PubMed ID: 2735237
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on adenocarcinoma of the prostate].
Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of incidental prostatic carcinoma].
Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
Hinyokika Kiyo; 1991 Feb; 37(2):135-9. PubMed ID: 2048491
[TBL] [Abstract][Full Text] [Related]
8. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
9. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
10. Orchidectomy and oestrogens as secondary forms of treatment for metastatic prostatic cancer.
Klijn JG; Nielander AJ; Alexieva-Figusch J; van Putten WL
Prog Clin Biol Res; 1985; 185A():335-49. PubMed ID: 4034579
[TBL] [Abstract][Full Text] [Related]
11. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
12. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis and treatment of carcinoma of the prostate with bone metastasis].
Kawai T; Washizuka M; Yamauchi T; Ishibashi Y; Sumi S; Kokuho M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1704-9. PubMed ID: 3592710
[TBL] [Abstract][Full Text] [Related]
14. [Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy].
Tsukamoto T; Fukui I; Kihara K; Goto S; Kitahara S; Kobayashi T; Kojima S; Oshima H
Hinyokika Kiyo; 1996 May; 42(5):351-6. PubMed ID: 8752537
[TBL] [Abstract][Full Text] [Related]
15. Prostate specific antigen doubling time after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy.
Rabbani F; Perrotti M; Bastar A; Fair WR
J Urol; 1999 Mar; 161(3):847-52. PubMed ID: 10022699
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 169 patients with prostate cancer].
Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
[TBL] [Abstract][Full Text] [Related]
19. External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy.
Takada C; Ito K; Nishi J; Yamamoto T; Hatanaka Y; Baba Y; Takahashi M
Radiat Med; 1995; 13(6):297-300. PubMed ID: 8850371
[TBL] [Abstract][Full Text] [Related]
20. [Prostatic cancer in the young adult].
Sfaxi M; Miladi M; Bacha K; Zermani R; Chebil M; Ayed M
Prog Urol; 2003 Apr; 13(2):313-5. PubMed ID: 12765073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
